{"url_path":"/sec/prph/10-k/2026/item-16","section_key":"item-16","section_title":"Item 16 Form 10-K Summary","topic":"sec","document":{"doc_type":"10-K","doc_date":"2026-06-01","source_url":"https://www.sec.gov/Archives/edgar/data/868278/0000868278-26-000005-index.html","accession_number":"0000868278-26-000005","cik":"0000868278","ticker":"PRPH","issuer_name":"ProPhase Labs, Inc.","edgar_url":"https://www.sec.gov/Archives/edgar/data/868278/0000868278-26-000005-index.html","primary_entity_key":"0000868278","primary_entity_name":"ProPhase Labs, Inc."},"word_count":139,"has_tables":true,"body_markdown":"Item 16    Form 10-K Summary\n\nNone.\n\n84\n\n[Table of Contents](#i488b31e4b35d426dbc5f2bf20556ba36_7)\n\nSIGNATURES\n\nPursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.\n\nPROPHASE LABS, INC.\n\nBy:/s/ Ted Karkus\n\nTed Karkus, Chairman of the Board,\n\nChief Executive Officer and Director\n\nPursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons on behalf of the registrant and in the capacities and on the dates indicated:\n\nSignatureTitleDate\n\n/s/ Ted KarkusChairman of the Board and Chief Executive Officer June 1, 2026\n\nTed Karkus(Principal Executive Officer, Principal Financial Officer and Principal Accounting Officer)\n\n/s/ Louis GleckelDirector June 1, 2026\n\nLouis Gleckel\n\n/s/ Carolina AbenanteDirector June 1, 2026\n\nCarolina Abenante\n\n85"}